Hints and tips:
Related Special Reports
...Hatchett says the rollout has suffered because of a lack of a “centre of power”....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...To borrow from another industry experiencing existential angst, it is like BP not only pursuing wind and solar power in the transition away from fossil fuels, but getting into flood prevention and forest...
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...“I wouldn’t say that we’re behind schedule,” says Richard Hatchett, chief executive of Cepi. “We’re just on the cusp of beginning to deliver doses.”...
...Going forward, the federal government has ordered that only Euro-V standard fuels can be imported. Elsewhere, banks have announced policies to end financing for coal-powered plants....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...Among Tsuyoshi Yoshiwara’s clients is an 87-year-old widow who owns a mountain and a forest in a rural area just outside Tokyo....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...At the foot of the Lingfeng Peaks in Zhejiang Province, nestled in bamboo forests, lies the Club Med Joyview Anji Resort....
...Now the Post has a hard time getting money to get a hotel room to cover a forest fire.”...
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...“The general use case in regards to provenance, whether pharmaceuticals or food, is getting a lot of traction because of the usually problematic long supply chain from raw materials to the end consumer,”...
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...the neuroscience business should not “shock investors but is likely to raise a debate over possible use of proceeds should any cash be generated and management of any earnings dilution [ie deleveraging v...
...Despite the remoteness of the region, the WHO had managed to get two laboratories and safe burial equipment into the forest using aircraft and motorbikes....
...At Allergan, however, he said he was “very supportive” of Mr Saunders, a powerful player in the pharmaceuticals industry’s recent frenzy of dealmaking....
...Some disputes continue long after the patent has expired — as is often the case in the oil and gas, and pharmaceutical industries. When and to whom was the first patent granted?...
...A white, low-rise, steel-and-glass building on the estate is the former headquarters of Forest Laboratories, now a division of Allergan following a series of tax-driven takeovers and name changes culminating...
...The traded market in commercial forests is worth £100m per year, according to the Forestry Commission. Gresham shares closed at 337.5p on Friday....
International Edition